Tuberculosis, lung infections, and interstitial lung disease in AJRCCM 2000.
Tobin
M J
MJ
Division of Pulmonary and Critical Care Medicine, Loyola University of Chicago Stritch School of Medicine, Hines, Illinois 60141, USA. mtobin2@luc.edu
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000453:epidemiology / Q000276:immunology / Q000628:therapy; D000818:Animals; D015415:Biomarkers / Q000032:analysis; D001987:Bronchiectasis / Q000175:diagnosis / Q000628:therapy; D003422:Critical Care / Q000379:methods / Q000592:standards / Q000639:trends; D004195:Disease Models, Animal; D015658:HIV Infections / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology / Q000276:immunology / Q000628:therapy; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000628:therapy; D016867:Immunocompromised Host; D007239:Infections / Q000175:diagnosis / Q000628:therapy; D008171:Lung Diseases / Q000175:diagnosis / Q000628:therapy; D017563:Lung Diseases, Interstitial / Q000175:diagnosis / Q000628:therapy; D008403:Mass Screening / Q000379:methods; D008967:Molecular Biology; D010506:Periodicals as Topic; D012307:Risk Factors; D012507:Sarcoidosis / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D012595:Scleroderma, Systemic / Q000175:diagnosis / Q000628:therapy; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy
D015415:Biomarkers